The F.D.A. is expected to soon authorize Pfizer-BioNTech’s booster for 5- to 11-year-olds.

https://www.nytimes.com/2022/05/16/us/politics/fda-pfizer-booster-children.html
Sharon LaFraniere
New York Times
May 16, 2022